ZYRTEC-D
- Product NDC
- 50580-728
- 11-digit product format
- 505800728
- Labeler code
- 50580
- Product ID
- 50580-728_375e77b2-d993-5d63-e063-6394a90af43d
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Kenvue Brands LLC
- Application
- NDA021150
- Marketing category
- NDA
- Marketing start
- 2008-01-01
- Substance
- CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 5; 120 mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021150-002 | ZYRTEC-D 12 HOUR | CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021150-002 | ZYRTEC-D 12 HOUR | 5MG;120MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2007-11-09 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021150-002 | 6469009 | 2019-07-13 | U-295 | Drug product | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021150-002 | 7014867 | 2022-06-10 | Drug product | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N021150-002 | 7226614 | 2022-06-10 | U-295 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021150-002 | 7014867 | 2022-06-10 | Drug product | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N021150-002 | 7226614 | 2022-06-10 | U-295 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021150-002 | 6469009 | 2019-07-13 | U-295 | Drug product | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021150-002 | 6469009 | 2019-07-13 | U-295 | Drug product | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021150-002 | 7014867 | 2022-06-10 | Drug product | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021150-002 | 7226614 | 2022-06-10 | U-295 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021150-002 | 6469009 | 2019-07-13 | U-295 | Drug product | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021150-002 | 7014867 | 2022-06-10 | Drug product | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021150-002 | 7226614 | 2022-06-10 | U-295 | ea99ee380514… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021150-002 | 7014867 | 2022-06-10 | Drug product | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021150-002 | 7226614 | 2022-06-10 | U-295 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N021150-002 | 7014867 | 2022-06-10 | Drug product | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | N021150-002 | 7226614 | 2022-06-10 | U-295 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N021150-002 | 7014867 | 2022-06-10 | Drug product | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N021150-002 | 7226614 | 2022-06-10 | U-295 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021150-002 | 7014867 | 2022-06-10 | Drug product | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021150-002 | 7226614 | 2022-06-10 | U-295 | cb3db0bc1861… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ZYRTEC-D
- Brand name suffix
- Allergy Plus Congestion
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CETIRIZINE HYDROCHLORIDE | 5 mg/1 |
| PSEUDOEPHEDRINE HYDROCHLORIDE | 120 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 64O047KTOA | Internal UNII lookup |
| 6V9V2RYJ8N | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1e8eb279-3522-40e4-8062-06b5354f0d29 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ba088a92-ab5e-b2d4-e908-f5ea691b7587 | Product name | 7 | 20210201 |
| c505bb17-4ff9-45f9-ac2d-bb9c8c9d35be | Product name | 1 | 20200304 |
| a255659f-db40-429d-8c07-5f173f330d9c | Product name | 1 | 20190402 |
| 0fdb98e2-b951-a1ce-5715-2b187ba500ef | Product name | 4 | 20170718 |
| e974e22d-8688-7d92-1e87-40c1079e170c | Product name | 3 | 20151125 |
| e8718272-64cb-4436-969b-176c3067c8f4 | Product name | 1 | 20150609 |
| 30c51294-7ae9-8007-7de6-58222684a0be | Product name | 1 | 20140508 |
| 4f26f669-fc6c-40ef-9e26-1c7b2390ee66 | Product name | 1 | 20140508 |
| 70a83adc-6047-bbea-5a08-dfd304aa47d2 | Product name | 1 | 20140508 |
| 858ce051-9941-aafc-8c7c-44a8e0227463 | Product name | 1 | 20140508 |
| b893258d-0942-3d8a-3411-056ea0788ff5 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50580-728-12 | ZYRTEC-DAllergy Plus Congestion | 6 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 6 | 10 | |
| 50580-728-12 | ZYRTEC-DAllergy Plus Congestion | 2 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 2 | 10 | |
| 50580-728-24 | ZYRTEC-DAllergy Plus Congestion | 4 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 4 | 10 | |
| 50580-728-24 | ZYRTEC-DAllergy Plus Congestion | 6 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 6 | 10 | |
| 50580-728-25 | ZYRTEC-DAllergy Plus Congestion | 6 in 1 BLISTER PACK | TABLET, FILM COATED, EXTENDED RE | 6 | 10 | |
| 50580-728-25 | ZYRTEC-DAllergy Plus Congestion | 4 in 1 CARTON | TABLET, FILM COATED, EXTENDED RE | 4 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50580-728-12 | EA - Each | 50580-728 | d0f8dc94-f3d3-4f79-9906-bf744f35ba7c | 1 | 2012-07-24 |
| 50580-728-24 | EA - Each | 50580-728 | 2ab6ec96-62b6-4493-a4fd-83a4e755e010 | 1 | 2012-07-24 |
| 50580-728-50 | EA - Each | 50580-728 | 77517b86-5159-4401-91d0-bba7da9265e8 | 1 | 2012-07-24 |
| 50580-728-52 | EA - Each | 50580-728 | 47ad8f49-81c5-4e64-b5ba-f4416dbe1a70 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50580-728 | ZYRTEC-D ALLERGY PLUS CONGESTION (CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [KENVUE BRANDS LLC] | 9 | Current NDC, Legacy NDC, 6 package rows | 20241109_1e8eb279-3522-40e4-8062-06b5354f0d29.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZYRTEC-D | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | Kenvue Brands LLC | f1ecf9ba-1c03-7fb7-e053-2a95a90a875a | 2026-04-06 | Warnings | 021150 NDA021150 |
| ZYRTEC-D Allergy Plus Congestion | CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | Kenvue Brands LLC | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 2025-06-12 | Warnings | 021150 NDA021150 50580-728 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1014571 | cetirizine HCl 5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | PSN | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014583 | ZyrTEC-D Allergy & Congestion 5 MG / 120 MG 12HR Extended Release Oral Tablet | PSN | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014583 | 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Zyrtec-D] | SBD | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014571 | 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | SCD | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014571 | cetirizine dihydrochloride 5 MG / pseudoephedrine HCl 120 MG 12 HR Extended Release Oral Tablet | SY | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014583 | Zyrtec-D (cetirizine dihydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG) 12 HR Extended Release Oral Tablet | SY | 1e8eb279-3522-40e4-8062-06b5354f0d29 | 10 |
| 1014571 | cetirizine HCl 5 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Tablet | PSN | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
| 1014583 | ZyrTEC-D Allergy & Congestion 5 MG / 120 MG 12HR Extended Release Oral Tablet | PSN | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
| 1014583 | 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Zyrtec-D] | SBD | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
| 1014571 | 12 HR cetirizine hydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | SCD | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
| 1014571 | cetirizine dihydrochloride 5 MG / pseudoephedrine HCl 120 MG 12 HR Extended Release Oral Tablet | SY | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
| 1014583 | Zyrtec-D (cetirizine dihydrochloride 5 MG / pseudoephedrine hydrochloride 120 MG) 12 HR Extended Release Oral Tablet | SY | 3c9d819d-0f3f-4c76-9770-cf004b10299a | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50580-728-12 | 50580072812 | 2 BLISTER PACK in 1 CARTON (50580-728-12) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK | 2 blister pack | 2008-01-01 | 0000-00-00 | No | No | Current |
| 50580-728-24 | 50580072824 | 4 BLISTER PACK in 1 CARTON (50580-728-24) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK | 4 blister pack | 2008-01-01 | 0000-00-00 | No | No | Current |
| 50580-728-25 | 50580072825 | 4 BLISTER PACK in 1 CARTON (50580-728-25) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK | 4 blister pack | 2008-01-01 | 0000-00-00 | No | No | Current |